AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
TORONTO -- Metformin is often the only drug needed to achieve ovulation and conception in patients with polycystic ovary syndrome, according to a study presented at the annual meeting of the Society for Gynecologic Investigation.
And even patients who require additional therapy with clomiphene citrate often need only small doses, said Dr. Michael Heard, a fellow in reproductive endocrinology at the Baylor College of Medicine, Houston.
"Often PCOS [polycystic ovary syndrome] patients have failed many previous attempts to get pregnant, including high doses of clomiphene citrate and in vitro fertilization. When you think of the emotional and financial cost of this, our study is good news," Dr. Heard said.
Merformin is an oral hypoglycemic drug used primarily in the treatment of diabetes. In PCOS patients, the drug has been shown to induce regular menses and ovulation; correct hyperinsulinemia, which is believed to play a role in the pathogenesis of PCOS; and reduce levels of luteinizing hormone, sex hormone --binding globulin, and ovarian androgens.
This study is one of the first to look at conception rates and time to conception for PCOS patients on metformin, he said in an interview.
A total of 49 oligomenorrheic patients with PCOS entered the study, many of them having failed multiple previous cycles on clomiphene. They were initially treated with 500 mg of metformin twice a day for a ...
Source: HighBeam Research, Metformin May Be Only Drug Needed for Ovulation in PCOS.